These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 5784251

  • 1. [Clinical study of carbocromen (chromonar), new coronary vasodilator].
    Mallion JM, Denis B, Rival M.
    J Med Lyon; 1969 Mar 05; 50(160):411-3. PubMed ID: 5784251
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Experimental and clinical studies with a new coronary and heart-active substance].
    Moll A, Petzel H.
    Z Kreislaufforsch; 1967 Jan 05; 56(1):46-58. PubMed ID: 5595482
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of severe coronary insufficiency with Intensain].
    Friese G, Eisenbarth D.
    Med Welt; 1968 Sep 07; 36():1896-904. PubMed ID: 5716633
    [No Abstract] [Full Text] [Related]

  • 8. [Our experience with a new medication administered orally in the treatment of coronary insufficiency].
    Herreman F.
    Sem Hop; 1966 Dec 15; 42():Suppl:13-8. PubMed ID: 4296253
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of acute and chronic coronary insufficiency with carbochromen].
    Popov VG, Beljakova TI, Sophijeva IJ.
    Arzneimittelforschung; 1970 Mar 15; 20():467-8. PubMed ID: 5468733
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The use of imolamine in intravenous administration is ischemic cardiopathy].
    Catenazzo G, Tadini G, Mantero O.
    Clin Ter; 1977 Jun 15; 81(5):433-51. PubMed ID: 884937
    [No Abstract] [Full Text] [Related]

  • 13. [Control of the angina pectoris pain by intensain].
    Gille H, Rausch F.
    Med Welt; 1966 Apr 02; 14():715-9. PubMed ID: 5957301
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The effects of 3-(beta-diethylaminoethyl)-4-methyl-7-carbothoxymethoxy-2-oxo-(1,2-chromene)-hydrochloride and nitroglycerin on cardiovascular dynamics in healthy and coronary diseased hearts].
    Pippig L, Schneider KW.
    Arzneimittelforschung; 1965 Sep 02; 15(9):1008-19. PubMed ID: 4955785
    [No Abstract] [Full Text] [Related]

  • 16. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris].
    Calandre L, Ruano JM.
    Rev Esp Cardiol; 1965 Apr 02; 18(2):168-72. PubMed ID: 5319557
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R, Persić T, Custović F.
    Arzneimittelforschung; 1970 Mar 02; 20():454-6. PubMed ID: 4916580
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled clinical study of a coronary active drug (etaphenone chlorhydrate) for parenteral administration].
    Del Giallo P, Valiensi M.
    Minerva Cardioangiol; 1972 Nov 02; 20(11):642-57. PubMed ID: 4566131
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.